Effect of progestational compounds on ovarian endometriosis.
D000328:Adult; D004715:Endometriosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008234:Lynestrenol / Q000627:therapeutic use*; D008656:Mestranol / Q000627:therapeutic use*; D010049:Ovarian Diseases / Q000188:drug therapy*
D008656:Mestranol; D008234:Lynestrenol